Health
Chronicle Pharmabiz
RDIF to promote pharma & medical devices research
RESEARCH by private firms in the field of pharmaceuticals and medical devices is one among the sunrise sectors that will benefit from the Central government's newly launched Rs. 1 lakh crore Research Development and Innovation Fund (RDIF).
2 min |
November 13, 2025
Chronicle Pharmabiz
New TNCDA acting secretary plans for major reforms
The Tamil Nadu Chemists and Druggists Association (TNCDA) is charting a course towards organizational renewal as the newly appointed acting secretary A Palaniappan has committed to make major reforms aimed at strengthening and unifying the trade body.
1 min |
November 13, 2025
Chronicle Pharmabiz
Medanta opens advanced surgical heart failure clinic
MEDICITY, one of India's leading super-speciality hospitals, ranked the Best Private Hospital in India by Newsweek for six consecutive years, has announced the launch of its Advanced Surgical Heart Failure Clinic, a specialized centre dedicated to the diagnosis, surgical management, and holistic rehabilitation of patients with complex and end-stage heart failure.
1 min |
November 13, 2025
Chronicle Pharmabiz
Pharmexcil to organise India Pavilion at World Health Expo
THE Pharmaceuticals Export Promotion Council of India (Pharmexcil) will be organising India Pavilion in 522 square meters of space with 61 stalls at World Health Expo (WHX), Dubai, UAE between February 09 and 12, 2026.
2 min |
November 13, 2025
Chronicle Pharmabiz
Pharmexcil to organize biz delegation to LAC region
THE Pharmaceuticals port Promotion Council of India (Pharmexcil) with the support of the Union ministry of commerce is organizing business delegation to Chile, Peru, Guatemala and Colombia between December 1, 2025 and December 12, 2025. The delegations' visit and its dates have been shared with the missions and received confirmation for the same.
1 min |
November 13, 2025
Chronicle Pharmabiz
Green Vision Centres shape sustainable eye care for future
INDIAN ophthalmology's Green Vision Centre is an innovative model that combines clinical efficiency with environmental sustainability, setting a new standard for inclusive healthcare delivery.
2 min |
November 13, 2025
Chronicle Pharmabiz
TN becomes second state to mandate NFI subscription for pharmacists
THE Indian Pharmacopoeia Commission (IPC) is set to sign a Memorandum of Understanding (MoU) with the Tamil Nadu State Pharmacy Council (TN SPC) for mandating the subscription of the National Formulary of India (NFI) for all newly registered pharmacists.
2 min |
November 13, 2025
Chronicle Pharmabiz
NPPA revokes its direction refusing discontinuation of GSK's Grisovin FP 250
THE National Pharmaceutical Pricing Authority (NPPA) has revoked its earlier decision under which the Authority had refused discontinuation of antifungal scheduled formulation Grisovin FP 250 mg, from pharma major GlaxoSmithKline Pharmaceuticals (GSK), observing that there are other players in the market and the company's market share for the drug is low.
1 min |
November 13, 2025
Chronicle Pharmabiz
Zydus gets US FDA ODD for Desidustat
ZYDUS, a leading, discovery-based, global pharmaceutical company today announced that the US Food & Drug Administration has granted Orphan Drug Designation (ODD) to Desidustat, a novel oral HIF-PHI, for the treatment of beta-thalassemia.
1 min |
November 13, 2025
Chronicle Pharmabiz
State DCs to take action not implementing Sch M
Action will be initiated right now for those units who have not applied for the extension, as the revised Schedule M is already applicable for such units,” said Dr Rajeev Singh Raghuvanshi, DCGI.
4 min |
November 13, 2025
Chronicle Pharmabiz
Eli Lilly expands executive team for next wave of growth
ELI Lilly and Company, a global medicine company turning science into healing to make life better for people across the world, has announced the appointment of two new executive committee members and the expansion of other senior leaders' roles designed to accelerate one of the industry's most ambitious pipelines, generate new portfolio opportunities, and strengthen patient access to its medicines.
1 min |
November 13, 2025
Chronicle Pharmabiz
Indian API cos want protectionist policies like anti-dumping duties, MIP
THE Indian API (active pharmaceutical ingredient) companies are now facing the major challenge of continued dumping of APIs by China at unreasonably low prices.
2 min |
November 13, 2025
Chronicle Pharmabiz
Biocon Biologics, Civica expand US insulin access
BIOCON Biologics, a global leader in biosimilars and the world's fourth-largest insulin producer, has announced the expansion of its strategic partnership with Civica, Inc., a US-based non-profit pharmaceutical company to include a new insulin glargine medicine that will benefit patients in the United States by increasing supply of highquality affordable insulins.
1 min |
November 13, 2025
Chronicle Pharmabiz
Alembic gets US FDA final nod for dasatinib tablets
ALEMBIC Pharmaceuticals Limited (Alembic), a verti pharmaceutically integrated research and development cal company, announced that it has received final approval from the US Food & Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) dasatinib tablets, 20 mg, 50 mg, 70 mg, 80 mg, 100 mg, and 140 mg.
1 min |
November 13, 2025
Chronicle Pharmabiz
DCGI asks State DCs to take action on SMEs not implementing Sch M
THE Central Drugs Standard Control Organisation (CDSCO) has asked the drug controllers (DCs) of the States and Union Territories (UT) to start immediate inspection and action on the units under Rs. 250 crore turnover, who have not applied for the extension of timeline for implementation of Revised Schedule M, without waiting for the deadline to be over.
1 min |
November 13, 2025
Chronicle Pharmabiz
Export of bulk drugs, intermediates grows over 8.3% in H1FY26
EXPORTS of bulk drugs and intermediates reported a growth of 8.33% in the first half of the current fiscal year on a YoY basis, reporting a trade surplus of almost $229 million for the period.
2 min |
November 13, 2025
Chronicle Pharmabiz
Recent developments in Bangladesh pharma industry
Over the past four decades, the pharmaceutical industry in Bangladesh has undergone a sweeping transformation- emerging from its modest, import-dependent roots into a powerful, innovation-driven sector at the forefront of national development. What once relied heavily on foreign suppliers for basic medicines has now evolved into a self-reliant, technologically advanced industry capable of producing everything from lifesaving generics to complex oncology drugs.
7 min |
October 30, 2025
Chronicle Pharmabiz
Asia Labex showcases latest advancements in lab technology
DRIVEN by increased investment in pharmaceutical and biotech R&D, a rising need for advanced diagnostic equipment due to disease prevalence, and the growing adoption of automation in labs, the pharma laboratory equipment market has positive prospects.
6 min |
October 30, 2025
Chronicle Pharmabiz
AMMOI demands insurance for Ayurveda day care therapies
THE Ayurvedic Medicine Manufacturers Organ- isation of India (AM- MOI) has sought Union Ayush Minister Prataprao Jadhav's immediate interven- tion to ensure health insurance covers for Ayurvedic day care therapies.
2 min |
October 30, 2025
Chronicle Pharmabiz
Global API market poised for significant changes
The global API market is poised for significant transformation in the coming decade, with growth concentrated in complex APIs, biologics, peptides, and high-potency APIS (HPAPIs).
6 min |
October 30, 2025
Chronicle Pharmabiz
PvPI identifies 16 India specific signals
THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been communicated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.
2 min |
October 30, 2025
Chronicle Pharmabiz
CDSCO sets up digital system to monitor quality of solvents
THE Central Drugs Standard Control Organisation (CDSCO) has set up a Digital Monitoring System on the Online National Drugs Licensing System (ONDLS) portal to monitor the supply chain as well as quality of the high-risk solvents and has asked the State drug controllers to direct all manufacturers of pharma grade solvents to obtain manufacturing license through the portal.
2 min |
October 30, 2025
Chronicle Pharmabiz
Surgicals import grows 11.58%, exports remain stagnant in August
IMPORTS of surgical equipment to the country have reported a decline of 11.58% even as the export of these products was almost stagnant during the month of August, 2025. For the first five months of the current fiscal, imports registered almost 9% growth compared to the same period a year ago.
2 min |
October 30, 2025
Chronicle Pharmabiz
API China focuses on innovation & global co-operation
In recent years, the scale of China's pharmaceutical active pharmaceutical ingredients (APIs) and its global market share have gradually increased. The China API market is experiencing significant growth, driven by expanding global pharmaceutical demand, an aging population, rising chronic disease rates, and the expiration of patents boosting demand for generics.
6 min |
October 30, 2025
Chronicle Pharmabiz
PVPI identifies 16 India specific signals
THE Pharmacovigilance Programme of India (PvPI) under the Indian Pharmacopoeia Commission (IPC) has identified 16 India specific signals. The same has been com- municated to the Central Drugs Standard Control Organisation (CDSCO) for timely regulatory interventions towards patient safety.
2 min |
October 30, 2025
Chronicle Pharmabiz
PM&AC 2025 redefines excellence in pharma manufacturing
THE 7th Annual Pharma Manufacturing & Automation Convention (PM&AC) 2025, co-located with the Pharma Manufacturing & Automation Excellence Awards, concluded on October 8 and 9 at Novotel HICC, Hyderabad, with resounding success.
3 min |
October 30, 2025
Chronicle Pharmabiz
CDSCO lists 1,700 standards under MHD to help industry
THE Central Drugs Standard Control Organisation (CDSCO) has listed out around 1,700 standards published under the Medical Equipment and Hospital Planning (MHD) of the Bureau of Indian Standards (BIS) so far, in an effort to help the industry to comply with the standards for their specific products.
1 min |
October 30, 2025
Chronicle Pharmabiz
Calibration and validation of analytical instruments
INNOVATIVE analytical instruments, ranging from a simple apparatus to complex computerized systems, are used in the pharmaceutical sector to get accurate data and to help ensure that products meet their specifications.
4 min |
October 30, 2025
Chronicle Pharmabiz
CDSCO lists 1,700 standards under MHD to help industry
THE Central Drugs Standard Control Organisation (CDSCO) has listed out around 1,700 standards published under the Medical Equipment and Hospital Planning (MHD) of the Bureau of Indian Standards (BIS) so far, in an effort to help the industry to comply with the standards for their specific products.
1 min |
October 30, 2025
Chronicle Pharmabiz
China stands tall in API production and exports
THE Active Pharmaceutical Ingredient (API) is the most important part of any drug. The API, as the name would suggest, is the chemical part of any capsule or tablet that works on the disease condition or symptom. This means that the API is the backbone of the pharmaceutical industry, booming in its own right, as it provides the ingredients for all kinds of medication. As the world's largest API production and exporting country, China can produce thousands of species of chemical raw materials.
4 min |